Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

One consultant urologist explains how focal therapy can minimise the risks of side effects such as incontinence and erectile ...

HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...

Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.

This is a rare opportunity for me personally, this is my only hope to extend my life by any real period at all." ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in ...

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a ...

"This is changing the way we practice prostate cancer." White House chief of staff Susie Wiles has breast cancer. She'll join ...